MyofascialPainSyndrome:AComprehensiveSystematicLiteratureReviewonDiagnosticApproaches,TreatmentModalitiesandRecentAdvances

Myofascial pain syndrome (MPS) is one of the most common causes of chronic musculoskeletal pain worldwide, affecting more than three-quarters of the global population at some point. Despite its prevalence, MPS remains frequently overlooked and underdiagnosed. The condition is characterized by myofascial trigger points (MTrPs)—hyperirritable, painful spots located in taut bands of skeletal muscle that produce both local and referred pain. MPS often coexists with emotional dysfunctions such as depression and anxiety, creating a complex clinical picture that can significantly impair quality of life and work capacity.

The prevalence of MPS is particularly challenging to determine due to the lack of clearly defined, universally accepted diagnostic criteria. Some studies suggest that among young or middle-aged individuals visiting pain clinics, MPS occurs in 30%–46% of cases. In India specifically, chronic pain affects 19.3% of adults, with musculoskeletal pain being the most common cause. Among middle-aged adults (30–60 years), the mean prevalence of MPS is 37% in men and 65% in women.

Given the substantial burden of disability and healthcare costs associated with MPS, understanding current diagnostic approaches and treatment options is essential for clinicians and patients alike.

The authors conducted a comprehensive systematic literature review examining recent advancements in the diagnosis and management of myofascial pain syndrome. They searched three major databases—PubMed, Scopus, and Google Scholar—using keywords such as "skeletal muscle disorder," "MTrPs," "dry needling," "manual therapy," "diagnostic imaging," and "regenerative medicine." From an initial pool of 150 articles, 43 carefully selected articles published within the last five years were included in the final review. The authors followed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for data extraction and quality assessment. Each article was evaluated based on study design, sample size, methodology, relevance to MPS diagnosis and treatment, and reported outcomes.

The included studies were categorized by evidence level using the Oxford Centre for Evidence-Based Medicine (OCEBM) 2011 criteria. The review encompassed diverse study types: randomized controlled trials (12%), cohort studies (10%), observational studies (10%), systematic reviews, and expert consensus papers. The authors synthesized findings across multiple domains including epidemiology, pathophysiology, diagnostic methods, and treatment modalities ranging from conservative physical therapies to invasive interventions and emerging technologies.

The review identified several key findings across multiple areas. Regarding epidemiology, MPS represents the primary source of musculoskeletal pain in aging populations, with prevalence increasing significantly with age. The pathophysiology of MTrPs involves multiple interconnected theories: the muscle spindle theory (abnormal electrophysiological signals), scar tissue theory (inflammation with elevated bradykinin, substance P, TNF, IL-1, serotonin, and norepinephrine), and the widely discussed "dysfunctional energy crisis" theory involving impaired calcium handling, ischemia, hypoxia, and ATP depletion leading to sustained sarcomere contraction at 30% to 50% of maximum effort. Histopathological examination revealed that MTrP samples showed enlarged, rounded, contracted muscle fibers with asymmetrical sarcomere arrangements compared to normal controls.

For diagnosis, the review confirmed that no conclusive laboratory test or imaging technique exists for MPS. Diagnosis remains clinical, based on Travell and Simons' eight criteria including palpable taut bands, local twitch response, and characteristic referred pain patterns. However, emerging technologies show promise: magnetic resonance elastography (MRE) can detect increased shear stiffness in taut bands, and ultrasound imaging can identify hyperechogenic regions corresponding to trigger points, though operator dependence remains a limitation.

Regarding treatment, the review found that multiple modalities demonstrate efficacy. Non-pharmacological approaches include manual therapy (trigger point compression, myofascial release, spray and stretch), therapeutic exercise, kinesiology taping, electrotherapies (TENS, interferential current, therapeutic ultrasound, low-level laser therapy), and extracorporeal shockwave therapy (ESWT). Pharmacological options include NSAIDs, tricyclic antidepressants, SNRIs, anticonvulsants (gabapentin, pregabalin), muscle relaxants, and topical agents. Invasive therapies encompass dry needling, acupuncture, trigger point injections with local anesthetics or corticosteroids, botulinum toxin, and emerging regenerative approaches including platelet-rich plasma (PRP) and stem cell therapy.

The review noted that botulinum toxin shows inconclusive efficacy based on four RCTs, while ESWT provided better pain relief than trigger point injection for quadratus lumborum myofascial pain. Dry needling and kinesio taping were found to have comparable outcomes for pain reduction and functional improvement.

Psychological factors emerged as critically important, with up to 85% of chronic pain patients experiencing severe depression, and chronic neck pain patients showing high rates of anxiety and depression. Exercise, yoga, and meditation demonstrated benefits for both pain and psychological symptoms. Technological innovations including AI, machine learning, wearable devices, and telemedicine were identified as emerging tools for personalized MPS management.

This systematic review highlights that MPS management requires a comprehensive, multimodal approach addressing both physical and psychological dimensions. For patients, this means that effective treatment likely involves combining several strategies rather than relying on a single intervention. The lack of definitive diagnostic tests means that finding a clinician experienced in trigger point examination remains important for accurate diagnosis. Patients should be aware that emotional factors like stress, anxiety, and depression commonly accompany MPS and that addressing these through exercise, mindfulness, or professional support can improve pain outcomes.

For clinicians, the review emphasizes the importance of thorough clinical examination skills since imaging and laboratory tests cannot confirm MPS. The comparable efficacy of dry needling and kinesio taping suggests flexibility in treatment selection based on patient preference, cost, and availability. The finding that ESWT outperformed trigger point injection for quadratus lumborum pain indicates that non-invasive options should be considered before injections for certain presentations. The inconclusive evidence for botulinum toxin suggests clinicians should carefully consider this option and discuss uncertainty with patients.

The review also points toward future directions: objective diagnostic tools like MRE and high-resolution ultrasound may eventually reduce diagnostic subjectivity. Regenerative approaches like PRP and stem cell therapy hold theoretical promise but require substantially more research. AI and machine learning applications could enable more personalized, predictive treatment approaches. However, the authors appropriately caution that many emerging technologies need validation through large-scale randomized trials before widespread adoption.

Cost, accessibility, and specialized training requirements currently limit availability of advanced interventions. Ultimately, integrating traditional treatments with carefully selected innovative approaches, while addressing psychological comorbidities, appears to offer the best path forward for improving quality of life in MPS patients.